Since joining Schlich in February 2015, Alex has become a key player in the firm, now leading our Chemical and Pharmaceutical patent team and responsible for major clients. In addition, Alex has a key role in the firm’s marketing strategy and day-to-day management as part of our Operations Committee (joining forces with George Schlich, Andrew Clements and Keira Denton).
Founder, George Schlich, commented: “This is well deserved, Alex, great to have your further dedication to the firm through your role as Director!”
This progression commemorates Alex’s hard work and dedication to the company and we congratulate him on his Directorship.